To direct the Commandant of the Coast Guard to update the policy of the Coast Guard regarding the use of medication to treat drug overdose, and for other purposes.

United States119th CongressHR-2351House of Representatives
Updated: Jun 10, 2025

Summary

This bill directs the Commandant of the Coast Guard to update its policy within one year to ensure the use of medication, such as naloxone , for treating drug overdoses, including those involving opioids and fentanyl. The updated policy must mandate that naloxone or similar medication is available for Coast Guard members on all installations and in every operational environment, with provisions for multi-facility installations. The legislation also requires the Coast Guard to participate in a national drug tracking system and for the relevant Secretaries to finalize a memorandum of understanding to facilitate this access within one year. Within two years, the Commandant must brief congressional committees on the policy's implementation, the prevalence of illegal fentanyl and controlled substances within the Coast Guard over the past five years, and the status of the tracking system and MOU. This briefing will also review instances where naloxone was used to treat overdoses. Finally, the bill amends federal law (46 U.S.C. 70503(a)) to clarify and strengthen prohibitions against manufacturing, distributing, or possessing with intent to distribute controlled substances on board covered vessels. All requirements under this act must adhere to applicable privacy laws, including the Privacy Act and HIPAA regulations.

Bill texts

Available versions
View official text

3 versions available

Timeline

  1. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2547-2548)

  2. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2547-2548)

    House of Representatives

  3. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  4. Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

    Senate